DNA sequence selectivity of human topoisomerase I-mediated DNA cleavage induced by camptothecin

Protein Sci. 2009 Jun;18(6):1326-31. doi: 10.1002/pro.138.

Abstract

In probing the mechanism of inhibition of hypoxia inducible factor (HIF-1) by campothecins, we investigated the ability of human topoisomerase I to bind and cleave HIF-1 response element (HRE), which contains the known camptothecin-mediated topoisomerase I cleavage site 5'-TG. We observed that the selection of 5'-TG by human topoisomerase I and topotecan depends to a large extent on the specific flanking sequences, and that the presence of a G at the -2 position (where cleavage occurs between -1 and +1) prevents the HRE site from being a preferred site for such cleavage. Furthermore, the presence of -2 T/A can induce the cleavage at a less preferred TC or TA site. However, in the absence of a more preferred site, the HRE site is shown to be cleaved by human topoisomerase I in the presence of topotecan. Thus, it is implied that the -2 base has a significant influence on the selection of the camptothecin-mediated Topo I cleavage site, which can overcome the preference for +1G. While the cleavage site recognition has been known to be based on the concerted effect of several bases spanning the cleavage site, such a determining effect of an individual base has not been previously recognized. A possible base-specific interaction between DNA and topoisomerase I may be responsible for this sequence selectivity.

MeSH terms

  • Base Sequence
  • Camptothecin / pharmacology*
  • DNA Cleavage*
  • DNA Topoisomerases, Type I / metabolism*
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Hypoxia-Inducible Factor 1 / genetics
  • Oligonucleotides / metabolism
  • Recombinant Proteins / antagonists & inhibitors
  • Recombinant Proteins / metabolism
  • Response Elements
  • Topoisomerase I Inhibitors

Substances

  • Enzyme Inhibitors
  • Hypoxia-Inducible Factor 1
  • Oligonucleotides
  • Recombinant Proteins
  • Topoisomerase I Inhibitors
  • DNA Topoisomerases, Type I
  • Camptothecin